BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15853473)

  • 1. Eletriptan in migraine.
    Diener HC
    Expert Rev Neurother; 2005 Jan; 5(1):43-53. PubMed ID: 15853473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eletriptan.
    Sandrini G; Perrotta A; Tassorelli C; Nappi G
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1587-98. PubMed ID: 19929447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
    Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
    Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rizatriptan in migraine.
    Krymchantowski AV; Bigal ME
    Expert Rev Neurother; 2005 Sep; 5(5):597-603. PubMed ID: 16162083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
    Diener HC; McHarg A
    Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eletriptan: a review and new perspectives.
    Sandrini G; Perrotta A; Nappi G
    Expert Rev Neurother; 2006 Oct; 6(10):1413-21. PubMed ID: 17078782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
    Silberstein SD; Cady RK; Sheftell FD; Almas M; Parsons B; Albert KS
    Headache; 2007 May; 47(5):673-82. PubMed ID: 17501848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
    Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B
    Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral almotriptan: practical uses in the acute treatment of migraine.
    Dowson AJ
    Expert Rev Neurother; 2004 May; 4(3):339-48. PubMed ID: 15853532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
    Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spanish contribution to the clinical development of eletriptan: an analysis of controlled studies].
    Pascual J; Leira R; Lainez JM; Liaño H; Díez-Tejedor E; Navarro A; Jiménez D; Ezpeleta D; Mateos V; Madrigal M; Palacios G;
    Neurologia; 2004 Oct; 19(8):414-9. PubMed ID: 15470580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
    Goldstein J; Tiseo PT; Albert KS; Li C; Sikes CR
    Headache; 2006; 46(7):1142-50. PubMed ID: 16866718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eletriptan for the acute treatment of migraine: results of bridging a Japanese study to Western clinical trials.
    Sakai F; Diener HC; Ryan R; Poole P
    Curr Med Res Opin; 2004 Mar; 20(3):269-77. PubMed ID: 15025836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
    Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing.
    Brandes JL; Kudrow D; Cady R; Tiseo PJ; Sun W; Sikes CR
    Cephalalgia; 2005 Sep; 25(9):735-42. PubMed ID: 16109056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
    Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
    Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eletriptan review.
    Färkkilä M; Kallela M
    Expert Opin Pharmacother; 2005 Apr; 6(4):625-30. PubMed ID: 15934888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation.
    Mandema JW; Cox E; Alderman J
    Cephalalgia; 2005 Sep; 25(9):715-25. PubMed ID: 16109054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.